Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2019-10-02 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 September 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other agreements or arrangements to issue shares. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory disclosure about share capital and securities movements, typical of a monthly return filing to a stock exchange. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports on changes in share capital and related securities.
2019-10-02 English
Interim Report 2019
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial data, including key financial highlights, condensed consolidated statements of profit or loss, financial position, cash flows, and changes in equity. It also includes a management discussion and analysis section, corporate information, and business review. The period covered is the six months ended 30 June 2019, indicating it is a half-year report. The document is about 15,000 characters long, which is substantial and contains actual financial statements and analysis, not just an announcement or summary. The presence of unaudited condensed consolidated interim results and detailed financial statements confirms this is an Interim / Quarterly Report. H1 2019
2019-09-13 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 13 September 2019 from Uni-Bio Science Group Limited informing shareholders that the 2019 interim report for the six months ended 30 June 2019 has been published on the company's website. It includes instructions on how shareholders can request a printed copy of the interim report and other corporate communications. The document does not contain the interim report itself or any substantive financial data, but rather serves as a notice of publication and a request form for printed copies. The document length is 4666 characters, which is relatively short and consistent with a notification rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR).
2019-09-13 English
CHANGE OF COMPANY SECRETARY
Board/Management Information Classification · 100% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a change in the company secretary. It details the resignation of the previous company secretary and the appointment of a new one, including their qualifications and experience. There is no financial data, report, or detailed analysis present. The document is short (2318 characters) and serves as a formal notification of a management change. According to the filing definitions, announcements about changes in senior management or board members fall under 'Board/Management Information' (MANG). Therefore, the correct classification is MANG with high confidence.
2019-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 August 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other agreements or arrangements to issue shares. The content is focused on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical of a capital/financing update. It is not an announcement of a report publication, nor a full annual or interim report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-09-05 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2019
Interim / Quarterly Report Classification · 95% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2019' and contains detailed unaudited condensed consolidated interim financial results, including revenue, profit/loss before taxation, segment results, and key financial highlights for the six months ended 30 June 2019. It also includes a Management Discussion and Analysis section discussing market review, business review, R&D progress, and operational highlights. The document length is about 15,000 characters, indicating it is a substantive report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which provides comprehensive financial data and analysis for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2019
2019-08-30 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.